Injectables marketing agency for Austin aesthetic practices — Westlake, Domain, Barton Hills, Tarrytown, built for the tech-worker demographic and inside TX Med Board 165.5

Why Austin injectable practices work with Ichelon Consulting US

Austin is a three-hour drive from our Dallas HQ. Our US office runs Central Time hours, and the Austin engagement pattern is a monthly on-site creative-capture visit to Westlake or Domain, quarterly Rule 165.5 back-catalog audits, and same-time-zone daily operations. Five factors concentrate why Austin injectable practices choose us.

First, we understand the Austin tech-worker buyer — the 27-to-38-year-old who researches product mechanism, reads injector bios, and expects price transparency before booking. Second, we treat preventative injectables and Baby Botox as their own funnel with a twelve-year-LTV thesis, not as a discount subset of general Botox marketing. Third, we scope every injectable product on its own compliance surface and treat the six-product catalog as one connected LTV motion. Fourth, we deliver from a Central Time zone with monthly Austin in-market presence — which matters for creative capture and Rule 165.5 audit. Fifth, we have never named a competitor Austin clinic in a marketing asset and we never will.

The engagement pattern most Austin injectable practices settle into is a three-to-six-month build-out — site audit, injectables catalog restructure, GBP density lift across Austin metro, preventative-injectables funnel scope, membership pricing structure — then a steady-state monthly retainer with quarterly compliance re-audits.

Texas Medical Board Rule 165.5 — how it applies to Austin injectable creative

Rule 165.5 of the Texas Administrative Code (22 TAC §165.5) applies identically in Austin as in Dallas or Houston — Texas is one state rule set. Chapter 200 on physician-owned med spas layers additional constraint. Austin enforcement has stepped up alongside the metro's clinic-density growth — the Board's complaint queue on Austin injectables clinics has increased steadily since 2023.

What Rule 165.5 requires on Austin injectable before/after content

• Signed, dated patient consent for every face-visible injectable before/after image or Reel — Botox, filler, Sculptra, Kybella, PDO threads, and PRP all trigger the same requirement.
• "Results not typical" or equivalent disclosure in the same field of view — Instagram carousel before/afters need disclosure on each slide.
• No filter, no post-production smoothing, no lighting change between frames.
• Time-stamped follow-ups labeled distinctly. This matters especially for the Austin preventative-injectable buyer, who wants to see six-month and twelve-month results — not just the two-week post-visit shot.
• Compensation disclosure on any incentivized content — FTC 16 CFR §255 and TX Rule 165.5 both apply, and Austin's creator-economy density means influencer content passes through the disclosure filter constantly.

Rule 165.1 — superiority language in Austin's tech-influenced buyer market

Rule 165.1 prohibits false, deceptive, and misleading communication. In Austin, "best injector in Austin," "leading Sculptra provider," "top-rated" language fails superiority testing. The Austin tech buyer is also allergic to superlative claims — they read as marketing puffery and reduce conversion. Category framing, credential specificity, and technique detail outperform superiority rhetoric on both a compliance and a conversion axis.

FDA 21 CFR §202.1 — on-label promotion for Austin injectable ads

Every FDA-approved injectable used in an Austin practice has a specific on-label indication. FDA 21 CFR §202.1 prohibits promotional communication for an unapproved use. That constraint sits on the manufacturer directly. For an Austin clinic, physicians can prescribe off-label — but the marketing surface is where FDA, TX Medical Board, and Meta ad policy converge.

On-label indications, Austin-relevant quick reference

• Neuromodulators: glabellar lines on-label across all six. Baby Botox as a technique (small units, glabellar-and-forehead maintenance) is inside the on-label indication when the anatomical area is on-label — creative frames it as a technique, not a separate FDA claim.
• HA fillers: each SKU has a specific on-label indication. Off-label injection sites (temples, chin projection, jawline, non-surgical rhinoplasty) are visit outcomes, not FDA indications in the creative.
• Biostimulators: Sculptra on-label for shallow-to-deep facial wrinkles and facial lipoatrophy. Radiesse on-label for moderate-to-severe wrinkles and hand rejuvenation. Hyperdilute Radiesse skin-quality applications are off-label.
• Threads: 510(k)-cleared for facial soft-tissue approximation. Non-surgical facelift language fails.
• PRP / PRF: autologous. No FDA aesthetic approval.
• Kybella: on-label for submental fat.

The Austin injectable consult and the multi-product ascension arc

Every marketing conversation about a single injectable becomes a conversation about the next injectable in the arc. The Austin preventative-injectable buyer who books a Baby Botox consult at 28 is often assessing whether this clinic will be her twelve-year injectable home — Botox at 28, add micro-filler at 31, Sculptra series at 35, PDO threads at 40, and maintenance across all of it.

Pre-visit intake — set the ascension up before the injector walks in

A well-structured Austin pre-visit intake asks about neuromodulator history, prior injector experience, glabellar and crow's feet concerns, but also lower-face concerns, texture concerns, volume concerns, scalp concerns for PRP candidates, and outdoor-lifestyle sun-exposure history (which the Austin buyer answers with detail unusual in other metros).

Post-visit sequence — the seven-to-twenty-eight-day window

A post-visit email + SMS sequence on day 3 / day 10 / day 21 / day 28 is worth more revenue-per-visit than any acquisition channel by itself. Every touchpoint is TCPA-compliant on SMS opt-in and CAN-SPAM-compliant on email. The Austin buyer engages heavily with post-visit content that includes injector video check-ins.

Provider talking-points sheet

Marketing produces the provider-facing talking-point sheet — how the ad campaign is framing the visit, what expectations the buyer walked in with, and how to bridge the neuromodulator consult to filler, Sculptra, thread, or PRP conversation.

Austin submarkets and neighborhoods we serve for injectables marketing

Westlake and Tarrytown carry the mature-buyer premium injectable spend. Domain and North Austin carry the tech-worker preventative-injectable buyer. Downtown and East Austin carry the emerging creative-class filler and Baby Botox demand. Barton Hills carries active-lifestyle buyer sun-damage protocols. Cedar Park, Round Rock, and Lakeway carry family-aesthetic demand at more accessible CPCs.

Retainer scope for Austin injectables clinic engagements

Retainers run custom-scoped from $2,500 to $8,000/month. Media spend is pass-through and scoped separately.

• Single-injector Westlake or Domain boutique — $2,500 to $4,000/month. SEO on two-to-three injectable product hubs, one GBP, Meta Ads on neuromodulator + filler intent, monthly reporting, quarterly Rule 165.5 audit.
• Two-to-three location Austin injectables group — $4,000 to $6,000/month. Full SEO across all six product families + GBP density + Google + Meta + Instagram + TikTok injector-brand + YouTube education + preventative-injectable funnel.
• Multi-location Austin platform or PE-backed group — $6,000 to $8,000+/month. Full stack + per-location P&L attribution + CRM integration + YouTube injector-authority publishing + FTC-disclosure influencer program + quarterly compliance re-audits.

Adjacent Austin and US marketing hubs